Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

dlee38

Rank: Mail Room [?]

Points: 165 [?]

Votes: 3 Score: 4.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

in response to

Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

KOO-KOO2

posted on Apr 05, 2022 06:13PM

If remdesivir is SoC, it has to be administered to eligible patients (unless there's a shortage).

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply